Payment overview · 2025
General Payments
$18.97
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert Geiger
Allopathic & Osteopathic Physicians|Family Medicine · ERIE, PA · NPI 1992769483
Verified facts
What the public records show
CMS Open Payments records show Robert Geiger received $18.97 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$18.97 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.97 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim |
Device | Medtronic, Inc. | $18.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 832 | 148 |
| Escitalopram Oxalate | Escitalopram Oxalate | 819 | 59 |
| Levothyroxine Sodium | Levothyroxine Sodium | 815 | 101 |
| Amlodipine Besylate | Amlodipine Besylate | 699 | 121 |
| Lisinopril | Lisinopril | 530 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 529 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 466 | 69 |
| Potassium Chloride | Potassium Chloride | 419 | 41 |
| Furosemide | Furosemide | 416 | 51 |
| Eliquis | Apixaban | 383 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 383 | 41 |
| Sertraline Hcl | Sertraline Hcl | 377 | 44 |
| Omeprazole | Omeprazole | 366 | 50 |
| Donepezil Hcl | Donepezil Hcl | 320 | 27 |
| Losartan Potassium | Losartan Potassium | 316 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 281 | 52 |
| Gabapentin | Gabapentin | 263 | 35 |
| Simvastatin | Simvastatin | 256 | 48 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 255 | 56 |
| Famotidine | Famotidine | 248 | 29 |
| Tramadol Hcl | Tramadol Hcl | 229 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 224 | 27 |
| Metformin Hcl | Metformin Hcl | 222 | 48 |
| Bumetanide | Bumetanide | 221 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 215 | 38 |
| Xarelto | Rivaroxaban | 178 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 149 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 138 | 14 |
| Atenolol | Atenolol | 137 | 20 |
| Meloxicam | Meloxicam | 137 | 23 |
| Levetiracetam | Levetiracetam | 136 | suppressed |
| Memantine Hcl | Memantine Hcl | 130 | 17 |
| Carvedilol | Carvedilol | 126 | 17 |
| Spironolactone | Spironolactone | 126 | 16 |
| Olanzapine | Olanzapine | 122 | 11 |
| Jardiance | Empagliflozin | 121 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 119 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 114 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 44 |
| Mirtazapine | Mirtazapine | 109 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 108 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 106 | 23 |
| Ezetimibe | Ezetimibe | 104 | 16 |
| Finasteride | Finasteride | 104 | 16 |
| Prednisone | Prednisone | 103 | 16 |
| Alendronate Sodium | Alendronate Sodium | 98 | 11 |
| Lorazepam | Lorazepam | 95 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 95 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 13 |
| Celecoxib | Celecoxib | 79 | suppressed |
| Tradjenta | Linagliptin | 78 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 77 | 17 |
| Latanoprost | Latanoprost | 75 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 74 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | suppressed |
| Alprazolam | Alprazolam | 72 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 69 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 69 | 40 |
| Methotrexate | Methotrexate Sodium | 69 | suppressed |
| Folic Acid | Folic Acid | 68 | suppressed |
| Ibuprofen | Ibuprofen | 66 | suppressed |
| Sucralfate | Sucralfate | 66 | suppressed |
| Metolazone | Metolazone | 64 | suppressed |
| Nystatin | Nystatin | 62 | 26 |
| Baclofen | Baclofen | 61 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 58 | 12 |
| Glimepiride | Glimepiride | 58 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | suppressed |
| Pregabalin | Pregabalin | 55 | suppressed |
| Myrbetriq | Mirabegron | 54 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 51 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 50 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 49 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 47 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 42 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | suppressed |
| Irbesartan | Irbesartan | 41 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 40 | suppressed |
| Anastrozole | Anastrozole | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 21 |
| Synthroid | Levothyroxine Sodium | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Allopurinol | Allopurinol | 35 | 11 |
| Oxcarbazepine | Oxcarbazepine | 35 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 34 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | suppressed |
| Digoxin | Digoxin | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Lumigan | Bimatoprost | 31 | suppressed |
| Glipizide | Glipizide | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 30 | suppressed |
| Zonisamide | Zonisamide | 30 | suppressed |
| Diazepam | Diazepam | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Cholestyramine Light | Cholestyramine | 26 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Telmisartan | Telmisartan | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 25 | 11 |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Ozempic | Semaglutide | 25 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 18 |
| Topiramate | Topiramate | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 15 | 12 |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | 14 |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Tobradex | Tobramycin/Dexamethasone | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Azithromycin | Azithromycin | 12 | 12 |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.97 · 1 records | Medtronic, Inc. | INTELLIS ADAPTIVESTIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error